As the first Mohs/dermatologic surgeon in the Department of Dermatology at Harvard Medical School, Dr. Jessica Fewkes has made significant contributions to the field of dermatology throughout her career, including the creation of Mohs surgery units at both Beth Israel Deaconess Medical Center and the West Roxbury Veterans Administration Hospital.
She received her medical degree from the University of California, San Francisco School of Medicine and completed her internal medicine internship at Cedars-Sinai Medical Center, Los Angeles. Subsequently, she completed her residency in dermatology at Harvard Medical School, followed by her fellowship training in Mohs surgery at Duke University. Now, she is the Director of Mohs and Cutaneous Surgery at Mass. Eye and Ear and is an Assistant Professor of Otolaryngology and Dermatology at Harvard Medical School.
A board-certified dermatologist, Dr. Fewkes sees mainly skin cancer patients. Boston Magazine has named her on the “Best Doctors in Boston” list for dermatology each year since 2008. She has been an invited speaker at regional and national meetings, and has published several peer-reviewed papers in the field. In 2016, she received the Harvard Dermatology Resident Award for Excellence in Training, which is only one example demonstrating her dedication to teaching aspiring dermatologic surgeons.
Dr. Fewkes’s clinical interests include skin cancer, Mohs surgery, dermatologic surgery, cutaneous surgery, and sun damaged skin. Her research interests include skin cancer, Mohs surgery, and skin care.
Superficial basal cell carcinomas of the head and neck. Mina MA, Picariello A, Fewkes JL. Dermatol Surg. 2013 Jul;39(7):1003–8.
Acute excisional wounds treated with a tissue-engineered skin (Apligraf). Eaglstein WH, Alvarez OM, Auletta M, Leffel D, Rogers GS, Zitelli JA, Norris JE, Thomas I, Irondo M, Fewkes J, Hardin-Young J, Duff RG, Sabolinski ML. Dermatol Surg. 1999 Mar;25(3):195–201.
Correlation of histologic subtypes of primary basal cell carcinoma and number of Mohs stages required to achieve a tumor-free plane. Orengo IF, Salasche SJ, Fewkes J, Khan J, Thornby J, Rubin F. J Am Acad Dermatol. 1997 Sep;37(3 Pt 1):395–7.
Complications of cutaneous surgery in patients who are taking warfarin, aspirin, or nonsteroidal anti-inflammatory drugs. Otley CC, Fewkes JL, Frank W, Olbricht SM. Arch Dermatol. 1996 Feb;132(2):161–6.
Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: Implications for photodynamic treatment. Martin A, Tope WD, Grevelink JM, Starr JC, Fewkes JL, Flotte TJ, Deutsch TF, Anderson RR. Arch Dermatol Res. 1995;287(7):665–74.
Surgical pearl: A user-friendly dressing. Fewkes JL, Salasche SJ. J Am Acad Dermatol. 1993;29(4):633–35.
Metastasis lentigo maligna melanoma. Albert LS, Fewkes JL, Sober AJ. J Dermatol Surg Oncol. 1990;16:56–58.
Immunologic detection of markers of keratinocyte differentiation. Its use in neoplastic and preneoplastic lesions of skin. Kvedar JC, Fewkes J, Baden HP. Arch Pathol Lab Med. 1986 Mar;110(3):183–8.
Illustrated Atlas of Cutaneous Surgery. Fewkes JL, Pollack SV, Cheney M; New York: JB Lippincott; 1991. Book.
View a complete list of publications on pubmed.gov »